However, in newly emerging tumors, demands for TR1 greatly increase as this protein would seem to be required to sustain tumor growth, likely because of the increased demand for its reducing equivalents via the Trx1 pathway and, as shown in this work, DNA replication. Here, TXNRD1 is linked to neoplasm.